BMY

Bristol Myers Squibb Stock Analysis

AI Rating

Good
  • Quality6/10
  • Growth↑ 9/10
  • Value↓ 4/10
Bristol Myers Squibb sales and earnings growth
BMY Growth
Great
  • Revenue Y/Y↓ 1.42%
  • EPS Y/Y↑ 33.21%
  • FCF Y/Y↓ -9.00%
Bristol Myers Squibb gross and profit margin trends
BMY Profitability
Good
  • Gross margin ↑ 70.50%
  • EPS margin↑ 15.00%
  • ROIC 5Y↑ 5.82%
Bristol Myers Squibb recent dividend growth
BMY Dividends
  • Dividend yield 4.24%
  • Growth 3Y↑ 3.82%
  • Payout ratio↑ 70%
Bristol Myers Squibb net debt vs free cash flow
BMY Risk
Fair
  • Debt / Equity↑ 2.2
  • Debt / FCF↓ 2.9
  • Interest coverage↓ NA

Bristol Myers Squibb stock is less volatile than the overall market, so it's low risk. We give it a Fair risk rating.

↗ More Drug Manufacturers - General stocks